Jason Darmadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jason Darmadi has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Kholis Abdurachim Audah
Department of Biomedical Engineering, Swiss German University. Jl. Jalur Sutera Barat No. 15, Tangerang 15143, Banten, Indonesia
2 shared publications Amalda Siti Anisa
Swiss German University
1 shared publication- Amalda Siti Anisa
Department of Biomedical Engineering, Swiss German University, Tangerang 15143, Indonesia
1 shared publication Bimo Aryo Tejo
Universiti Putra Malaysia
1 shared publicationCahyo Budiman
Universiti Malaysia Sabah
1 shared publication- Conny Riana Tjampakasari
Universitas Indonesia
1 shared publication
Latest Publications
- Open Access
Tetra hydroxy ethyl disulfate disodium: a novel non-resistant antibacterial chelating agent
Discovery of novel antibacterial drugs is urgently required as common antibiotics have numerous side effects and are becoming less effective due to antibiotic resistance occurrences. Developing a novel class of antibacterial compounds without inducing the prevalence of resistance when used repeatedly against bacterial pathogens is presumably one of the best approaches to overcome this problem. Tetra hydroxy ethyl disulfate disodium (THES) is a novel antibacterial agent, capable of disrupting cell activity without any need for drug influx. In this study, the molecular interaction between THES, Gram-positive, and Gram-negative bacteria was investigated. It was suggested that THES possessed the desirable characteristics of a non-resistant bacterial agent with bactericidal properties. Additionally, the non-resistant characteristics of THES were validated as a novel antibacterial agent. The unique feature of THES was the property of chelation with its strong binding ability to target ligands. This binding played a major role in bacterial peptidoglycan porosity enlargement, resulting in lysis and cell death. The bacterial cell membrane porosity enlargement was confirmed by Scanning Electron Microscopy, Transmission Electron Microscopy, as well as Atomic Force Microscopy. These findings were further supported by the results from in silico analysis which showed that THES formed favorable interactions with peptidoglycan with a binding affinity of −4.7 kcal/mol. The minimum inhibitory concentration value against multidrug-resistant (MDR) bacteria was notably low, between 0.05 - 0.1%. Furthermore, the analysis of resistance over a seven-month course showed that Staphylococcus aureus did not develop resistant characteristics to repeated treatment to THES treatment. This study has also shown that bactericidal characteristics can be easily manipulated and modified for more preferable antibacterial activities, whilst yielding desirable pharmacokinetic/pharmacodynamics (PK/PD) properties. There are several advantages of THES as compared to common antibiotics, including its flexibility in the killing capacity of different microbial strains. The simplicity, efficacy, and non-resistant properties of THES make it a promising drug candidate or compound to combat the outbreak of MDR bacteria in the future.
Open AccessTetra hydroxy ethyl disulfate disodium: a novel non-resistant antibacterial chelating agent
Discovery of novel antibacterial drugs is urgently required as common antibiotics have numerous side effects and are becoming less effective due to antibiotic resistance occurrences. Developing a novel class of antibacterial compounds without inducing the prevalence of resistance when used repeatedly against bacterial pathogens is presumably one of the best approaches to overcome this problem. Tetra hydroxy ethyl disulfate disodium (THES) is a novel antibacterial agent, capable of disrupting cell activity without any need for drug influx. In this study, the molecular interaction between THES, Gram-positive, and Gram-negative bacteria was investigated. It was suggested that THES possessed the desirable characteristics of a non-resistant bacterial agent with bactericidal properties. Additionally, the non-resistant characteristics of THES were validated as a novel antibacterial agent. The unique feature of THES was the property of chelation with its strong binding ability to target ligands. This binding played a major role in bacterial peptidoglycan porosity enlargement, resulting in lysis and cell death. The bacterial cell membrane porosity enlargement was confirmed by Scanning Electron Microscopy, Transmission Electron Microscopy, as well as Atomic Force Microscopy. These findings were further supported by the results from in silico analysis which showed that THES formed favorable interactions with peptidoglycan with a binding affinity of −4.7 kcal/mol. The minimum inhibitory concentration value against multidrug-resistant (MDR) bacteria was notably low, between 0.05 - 0.1%. Furthermore, the analysis of resistance over a seven-month course showed that Staphylococcus aureus did not develop resistant characteristics to repeated treatment to THES treatment. This study has also shown that bactericidal characteristics can be easily manipulated and modified for more preferable antibacterial activities, whilst yielding desirable pharmacokinetic/pharmacodynamics (PK/PD) properties. There are several advantages of THES as compared to common antibiotics, including its flexibility in the killing capacity of different microbial strains. The simplicity, efficacy, and non-resistant properties of THES make it a promising drug candidate or compound to combat the outbreak of MDR bacteria in the future.
- Open Access
Indonesian Mangrove Sonneratia caseolaris Leaves Ethanol Extract Is a Potential Super Antioxidant and Anti Methicillin-Resistant Staphylococcus aureus Drug
Methicillin-resistant Staphylococcus aureus (MRSA) is an S. aureus strain that has developed resistance against ß-lactam antibiotics, resulting in a scarcity of a potent cure for treating Staphylococcus infections. In this study, the anti-MRSA and antioxidant activity of the Indonesian mangrove species Sonneratia caseolaris, Avicennia marina, Rhizophora mucronata, and Rhizophora apiculata were studied. Disk diffusion, DPPH, a brine shrimp lethality test, and total phenolic and flavonoid assays were conducted. Results showed that among the tested mangroves, ethanol solvent-based S. caseolaris leaves extract had the highest antioxidant and anti-MRSA activities. An antioxidant activity assay showed comparable activity when compared to ascorbic acid, with an IC50 value of 4.2499 ± 3.0506 ppm and 5.2456 ± 0.5937 ppm, respectively, classifying the extract as a super-antioxidant. Moreover, S. caseolaris leaves extract showed the highest content of strongly associated antioxidative and antibacterial polyphenols, with 12.4% consisting of nontoxic flavonoids with the minimum inhibitory concentration of the ethanol-based S. caseolaris leaves extract being approximately 5000 ppm. LC-MS/MS results showed that phenolic compounds such as azelaic acid and aspirin were found, as well as flavonoid glucosides such as isovitexin and quercitrin. This strongly suggested that these compounds greatly contributed to antibacterial and antioxidant activity. Further research is needed to elucidate the interaction of the main compounds in S. caseolaris leaves extract in order to confirm their potential either as single or two or more compounds that synergistically function as a nontoxic antioxidant and antibacterial against MRSA.
Open AccessIndonesian Mangrove Sonneratia caseolaris Leaves Ethanol Extract Is a Potential Super Antioxidant and Anti Methicillin-Resistant Staphylococcus aureus Drug
Methicillin-resistant Staphylococcus aureus (MRSA) is an S. aureus strain that has developed resistance against ß-lactam antibiotics, resulting in a scarcity of a potent cure for treating Staphylococcus infections. In this study, the anti-MRSA and antioxidant activity of the Indonesian mangrove species Sonneratia caseolaris, Avicennia marina, Rhizophora mucronata, and Rhizophora apiculata were studied. Disk diffusion, DPPH, a brine shrimp lethality test, and total phenolic and flavonoid assays were conducted. Results showed that among the tested mangroves, ethanol solvent-based S. caseolaris leaves extract had the highest antioxidant and anti-MRSA activities. An antioxidant activity assay showed comparable activity when compared to ascorbic acid, with an IC50 value of 4.2499 ± 3.0506 ppm and 5.2456 ± 0.5937 ppm, respectively, classifying the extract as a super-antioxidant. Moreover, S. caseolaris leaves extract showed the highest content of strongly associated antioxidative and antibacterial polyphenols, with 12.4% consisting of nontoxic flavonoids with the minimum inhibitory concentration of the ethanol-based S. caseolaris leaves extract being approximately 5000 ppm. LC-MS/MS results showed that phenolic compounds such as azelaic acid and aspirin were found, as well as flavonoid glucosides such as isovitexin and quercitrin. This strongly suggested that these compounds greatly contributed to antibacterial and antioxidant activity. Further research is needed to elucidate the interaction of the main compounds in S. caseolaris leaves extract in order to confirm their potential either as single or two or more compounds that synergistically function as a nontoxic antioxidant and antibacterial against MRSA.